Effectiveness of Bilateral Endoscopic Sphenopalatine Ganglion Block on Postoperative Pain After Septoplasty

Umraniye Education and Research Hospital

Status: Not yet enrolling

Conditions: Postoperative Pain

Treatments: Procedure: Sphenopalatine Ganglion Block

Study type: Interventional

Funder types: Other

Identifiers

NCT06695624

SPGB-FULYA

Details and patient eligibility

About

The aim of this clinical study will investigate the efficacy of sphenopalatine ganglion block in the treatment of postoperative pain.it will also be learnt whether it reduces the consumption of analgesics in postoperative pain.The main questions it aims to answer are:

Will the participants' need for painkillers decrease after the operation? Can sphenopalatine ganglion block be used for postoperative pain after septoplasty? The researchers will compare 2 groups with and without sphenopalatine ganglion block to see the effectiveness of sphenopalatine ganglion block.

Participants will:

Read the information Participants have been given about the sphenopalatine ganglion block.

In case of any side effects, please contact participant's doctor.

Full description

This randomised controlled study will be conducted in Umraniye Training and Research Hospital operating room between November 2024 and January 2025 after obtaining ethics committee and patient consent. Each patient will be informed about the procedures to be performed during anaesthesia and surgery and signed informed consent will be obtained before the procedure. Patients will undergo septoplasty by the same otolaryngology team.

A total of 50 participants (25 envelopes each with Group 1 and Group 2 written inside) will be kept closed for the patients participating in the study. Upon the patient's fulfilment of the conditions suitable for the study, it will be randomly determined which group he/she will be included in. Thanks to this randomisation, conscious or unconscious manipulations in the selection of patients to the study group will be prevented.

Enrollment: 50 estimated patients

Sex: All

Ages: 18 to 50 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Participants who will undergo septoplasty
• 18 to 50 years old
• ASA score 1 or 2

Exclusion criteria

• Under 18 or over 50 years of age
• ASA score III and above patient group
• The patient is allergic to any of the drugs used
• The patient has a contraindication to any of the drugs used
• Use of anticoagulant medication
• Failure of the patient to give consent
• Being pregnant
• Those with GCS retardation such as dementia, mental retardation
• Those with diagnosed headache

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

50 participants in 2 patient groups

group with sphenopalatine ganglion block

Active Comparator group

Description:

Sphenopalatine ganglion block will be performed for participants undergoing septoplasty.

Treatment:

Procedure: Sphenopalatine Ganglion Block

group without sphenopalatine ganglion block

No Intervention group

Description:

Sphenopalatine ganglion block will not be performed for participants undergoing septoplasty